COX2-related multicentric mixed-type Castleman's disease in a young man

被引:7
作者
Liu, J [1 ]
Han, SA
Ding, J
Wu, KC
Miao, JY
Fan, DM
机构
[1] Fourth Mil Med Univ, Xijing Hosp, Dept Digest Dis, State Key Lab Canc Biol, Xian 710032, Peoples R China
[2] Fourth Mil Med Univ, Xijing Hosp, State Key Lab Canc Biol, Xian 710032, Peoples R China
[3] Fourth Mil Med Univ, Xijing Hosp, Dept Digest Dis, Xian 710032, Peoples R China
来源
NATURE CLINICAL PRACTICE ONCOLOGY | 2005年 / 2卷 / 07期
关键词
angiofollicular lymph node hyperplasia; chemotherapy; COX2; inhibitor; multicentric mixed-type Castleman's disease;
D O I
10.1038/ncponc0219
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Background A 34-year-old male presented with a 5-month history of fatigue, anorexia, low fever, night sweats, and oliguria with edema of the eyelid, exacerbated by abdominal distension and mild diarrhea of 3 weeks duration. Physical examination showed positive signs of ascites, palpable spleen, slight abdominal tenderness and mild rebound tenderness in the lower abdomen, and edema of the lower limbs. Initial laboratory tests revealed abnormal liver biochemistry and increased protein concentration in the urine. Chest X-ray showed minimal pleural effusion in both sides of the thoracic cavity, and ultrasound detected moderate ascites, several small lymph nodes in the retroperitoneum, and mild splenomegaly with widening of the splenic vein. A lymph node biopsy established the diagnosis, and cytokine analysis in the serum revealed COX2 as the possible mediator. Investigations Abdominal paracentesis, chest X-ray, abdominal ultrasound, thoracic and abdominal CT scans, gastroscopy, colonoscopy, biopsies of the liver, bone marrow and lymph nodes, immunophenotype staining for lymphocytes, cytokine analysis. Diagnosis COX2-related multicentric mixed-type Castleman's disease. Management Chemotherapy and COX2 inhibitors.
引用
收藏
页码:370 / 375
页数:6
相关论文
共 12 条
[1]
CROS D, 1990, NEW ENGL J MED, V323, P895
[2]
Targeting angiogenic processes by combination rofecoxib and ionizing radiation [J].
Dicker, AP ;
Williams, TL ;
Grant, DS .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2001, 24 (05) :438-442
[3]
GABA AR, 1978, AM J CLIN PATHOL, V69, P86
[4]
The clinical behavior of localized and multicentric Castleman disease [J].
Herrada, J ;
Cabanillas, F ;
Rice, L ;
Manning, J ;
Pugh, W .
ANNALS OF INTERNAL MEDICINE, 1998, 128 (08) :657-662
[5]
An unusual presentation of Castleman's Disease: a case report [J].
Izuchukwu, IS ;
Tourbaf, K ;
Mahoney, MC .
BMC INFECTIOUS DISEASES, 2003, 3 (1)
[6]
Masferrer JL, 2000, CANCER RES, V60, P1306
[7]
Menke DM, 2002, AM J CLIN PATHOL, V117, P268
[8]
High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease [J].
Oksenhendler, E ;
Boulanger, E ;
Galicier, L ;
Du, MQ ;
Dupin, N ;
Diss, TC ;
Hamoudi, R ;
Daniel, MT ;
Agbalika, F ;
Boshoff, C ;
Clauvel, JP ;
Isaacson, PG ;
Meignin, V .
BLOOD, 2002, 99 (07) :2331-2336
[9]
The cyclooxygenase-2-selective inhibitors rofecoxib and celecoxib prevent colorectal neoplasia occurrence and recurrence [J].
Rahme, E ;
Barkun, AN ;
Toubouti, Y ;
Bardou, M .
GASTROENTEROLOGY, 2003, 125 (02) :404-412
[10]
Scott D, 2001, AM J HEMATOL, V66, P148